Why Should You Put Monster Beverage Corp (NASDAQ: MNST) On Your Portfolio?

Currently, there are 975.14M common shares owned by the public and among those 692.61M shares have been available to trade.

The company’s stock has a 5-day price change of -0.39% and 16.73% over the past three months. MNST shares are trading 21.75% year to date (YTD), with the 12-month market performance up to 24.88% higher. It has a 12-month low price of $43.32 and touched a high of $64.45 over the same period. MNST has an average intraday trading volume of 5.93 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.54%, 6.53%, and 19.02% respectively.

Institutional ownership of Monster Beverage Corp (NASDAQ: MNST) shares accounts for 65.64% of the company’s 975.14M shares outstanding.

It has a market capitalization of $62.41B and a beta (3y monthly) value of 0.61. The stock’s trailing 12-month PE ratio is 42.25, while the earnings-per-share (ttm) stands at $1.51. The company has a PEG of 3.60 and a Quick Ratio of 2.78 with the debt-to-equity ratio at 0.04. Price movements for the stock have been influenced by the stock’s volatility, which stands at 0.34% over the week and 0.99% over the month.

Earnings per share for the fiscal year are expected to increase by 14.52%, and 12.80% over the next financial year. EPS should grow at an annualized rate of 11.73% over the next five years, compared to 8.01% over the past 5-year period.

Looking at the support for the MNST, a number of firms have released research notes about the stock. Roth Capital stated their Neutral rating for the stock in a research note on May 14, 2025, with the firm’s price target at $50-$56. UBS coverage for the Monster Beverage Corp (MNST) stock in a research note released on May 09, 2025 offered a Neutral rating with a price target of $63. TD Cowen was of a view on May 09, 2025 that the stock is Hold, while Piper Sandler gave the stock Neutral rating on May 09, 2025, issuing a price target of $51- $54. Morgan Stanley on their part issued Overweight rating on May 09, 2025.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.